Introduction
============

Enterohemorrhagic *Escherichia coli* (EHEC) serotype O157:H7 is the leading cause of outbreaks of bloody diarrhea and is often associated with the triad of hemorrhagic colitis, thrombocytopenia, and renal failure in the United States (Karmali, [@B31]). The life threatening sequelae of EHEC infections are due to the production of Shiga toxins (Karmali, [@B31]; Noel and Boedeker, [@B49]; Teel et al., [@B60]). EHEC belongs to a unique subset of intestinal pathogens that cause attaching and effacing (AE) lesions on the intestinal epithelium during infection. AE lesions are histo-pathological alterations of the intestinal epithelial surface that are characterized by loss of brush border microvilli and formation of actin rich pedestals beneath bound bacteria (Pai et al., [@B50]). Enteropathogenic *E. coli* (EPEC) is a related intestinal pathogen that causes infantile diarrhea that also generates AE lesions in the host (Frankel et al., [@B23]; Nataro and Kaper, [@B48]; Celli et al., [@B14]; Campellone and Leong, [@B9]).

An \~35 kB pathogenicity island in *E. coli* O157:H7 termed the locus of enterocyte effacement (LEE) is required for AE lesion formation (McDaniel et al., [@B39]; McDaniel and Kaper, [@B40]). Some of the genes on the LEE required for AE lesion formation encode a type III secretion apparatus that injects bacterial effectors into host cells. The best-characterized secreted effector is translocated intimin receptor (Tir) which, when localized in the host cell membrane, serves as a receptor for intimin, a LEE encoded outer membrane adhesin. Intimin is necessary for intimate attachment to epithelial cells and its interaction with Tir is required for production of AE lesions at the enterocyte--bacteria interface. AE lesion formation can be conceptually divided into multiple stages: initial attachment of the bacteria to the host epithelia, type III secretion during which Tir and other *E. coli* secreted proteins (Esps) are translocated into host cells, and finally Intimin-mediated Tir ligation at the plasma membrane, which triggers host cell signaling events that lead to actin assembly (Donnenberg et al., [@B74]; Hayward et al., [@B27]; Frankel and Phillips, [@B24]; Campellone, [@B7]). Consistent with this model, mammalian cells injected with Esps delivered by a pre-infecting intimin-deficient EPEC mutant are capable of initiating robust actin focusing upon challenge with another strain or particle expressing intimin (Rosenshine et al., [@B54]; Liu et al., [@B37]).

Enterohemorrhagic *Escherichia coli* generates far fewer pedestals than EPEC on cultured mammalian cells. EHEC also exhibits relatively poor mammalian cell binding and actin pedestal formation on cultured monolayers after *in vitro* cultivation, in contrast to the robust AE lesion formation on intestinal epithelia observed during mammalian infection (Karch et al., [@B30]; Tzipori et al., [@B62]; Cantey and Moseley, [@B12]). This apparent paradox raises the possibility that growth in the mammalian host environment enhances the ability of EHEC to form AE lesions. To directly determine the relative efficiencies of virulence-associated phenotypes, we compared *in vitro*-cultured bacteria to EHEC isolated directly from infected piglets. We found that adaptation of EHEC to the mammalian host is associated with enhanced mammalian cell binding, increased amounts of intimin and Tir, better translocation of functional Tir, and dramatically more efficient pedestal formation on cultured mammalian cells.

Materials and Methods {#s1}
=====================

*In vitro* bacterial and tissue culture
---------------------------------------

The strains and plasmids used in this study are listed (Table [1](#T1){ref-type="table"}). To enhance biosafety, we and other labs routinely utilized an Stx-deficient derivative of EHEC EDL933 (Riley et al., [@B52]) when examining virulence features unrelated to toxin production. TUV93-0, lacking Stx, is predicted to be incapable of causing hemorrhagic colitis, but for simplicity, here we nevertheless refer to this as an "EHEC" strain. For infections, EHEC strains were cultured in LB, Miller (BD Difco) broth at 37°C with shaking for approximately 7 h, diluted 1:250 into DMEM with high-glucose (Gibco-BRL) supplemented with 100 mM HEPES (pH 7.4), and incubated at 37°C overnight without shaking (*in vitro*-cultured). It has been shown that there is maximal secretion of Esps by EHEC under these conditions (Ebel et al., [@B20]). *E. coli* K-12 strains were cultured in LB broth at 37°C with shaking. When appropriate, strains were cultured in media supplemented with 100 μg/mL of ampicillin (pInt or pIL22) or 35 μg/mL of Kanamycin A (pTir).

###### 

**Strains and plasmids used in this study**.

  Strain         Description                                        Designation   Source or reference
  -------------- -------------------------------------------------- ------------- ---------------------------------
  TUV93-0        Stx-derivative of EDL933                           WT            Donohue-Rolfe et al. ([@B19])
  KC5            EHEC TUV93-0 Δ*tir*                                Δ*tir*        Campellone et al. ([@B8])
  KM60           EHEC TUV93-0Δ*eae*                                 Δ*eae*        Murphy and Campellone ([@B45])
  MC1061         *E. coli* K-12F^-^Δ(lac)X74*ga*l/E *hsd*R *rps*L   K-12          Casadaban and Cohen ([@B13])
  **PLASMIDS**                                                                    
  pKC16          pK184-derivative producing EHEC Tir                pTir          Campellone et al. ([@B8])
  pHL6           pUC19-derivative producing EHEC Intimin            pInt          Liu et al. ([@B37])
  pIL22          pBR322-derivative producing AFA-1                  pIL22         Labigne-Roussel et al. ([@B35])

*HEp-2 cells (human laryngeal carcinoma cells) were cultured at 37°C in 5% CO~2~ in RPMI-1640 (Gibco-BRL) supplemented with 7% fetal bovine serum and 100 μg/mL penicillin, 100 μg/mL streptomycin, and 2 mM [l]{.smallcaps}-glutamine. HeLa cells (human cervical carcinoma) were cultured at 37°C in 5% CO~2~ in DMEM, high-glucose (Gibco-BRL) containing 10% FBS, 2 mM glutamine, and 50 μg/mL penicillin/streptomycin*.

Isolation of EHEC from infected gnotobiotic piglets
---------------------------------------------------

Piglets were delivered by cesarean section and maintained in microbiologic isolation (gnotobiotic) for 24 h and infected with an oral challenge \~5 × 10^9^ EHEC as described previously (Tzipori et al., [@B63], [@B61]). All animals were monitored daily for signs of clinical disease and euthanized 48--72 h after oral challenge.

To harvest bacteria from the intestines, both ileal and spiral colon were collected from each animal and flushed with chilled sterile PBS to remove the majority of gut contents and pooled. To obtain additional adherent EHEC, intestine sections were dissected and the mucosal surfaces were gently scraped with a sterile spatula, flushed with sterile PBS and combined with the initial washings. To separate EHEC from crude intestinal contents, the pooled preparation was centrifuged and washed five to six times with PBS (host-adapted EHEC). To quantitate EHEC density, cells were enumerated using a hemacytometer, re-suspended at 1 × 10^8^ bacteria/mL and confirmed by standard spread plating. The intestinal contents ("mucus" for use in control experiments) from uninfected piglets was obtained similarly.

In one set of control experiments, 20% "mucus" was supplemented to EHEC cultures grown in DMEM with high-glucose to determine whether *in vitro* growth in the presence of intestinal contents altered cell binding or pedestal formation. In a second set of control experiments, 20% "mucus" was added to *in vitro*-cultured EHEC immediately prior to cell binding and pedestal formation assays to determine whether mucus itself promoted mammalian cell binding or pedestal formation. In a third set of control experiments to differentiate between genetic (stable) and phenotypic (transient) adaptation, host-adapted EHEC were passaged *in vitro* as described previously and characterized for cell binding and pedestal formation.

Quantification of bacterial adherence
-------------------------------------

Bacterial adherence assays were performed as previously described (Liu et al., [@B36]). Briefly, HEp-2 cells were seeded in RPMI-1640 supplemented with 20 mM HEPES (pH 7.0), 2% fetal bovine serum, and 0.5% [d]{.smallcaps}-mannose (RHFM medium), infected with approximately 5 × 10^5^ bacteria for an MOI of approximately 10, and incubated for 3 h. Infected monolayers were washed six times in PBS to remove unbound bacteria and lysed with 0.5% TritonX-100. The cell lysates were serially diluted and plated on LB agar to determine the percent of bound bacteria. Significant differences from binding by *in vitro*-cultured EHEC was determined using a two-tailed, paired, Student's *t*-test and defined as a probability of *P* ≤ 0.05.

Assessment of actin pedestal formation
--------------------------------------

To quantitate the ability of EHEC strains to form pedestals on mammalian cells, coverslips that had been seeded with HEp-2 cells in RHFM (as described above) were infected with 5 × 10^5^ EHEC. After 3 h incubation at 37°C, the monolayers were washed with PBS and further incubated for 3 h after addition of fresh RHFM. The cells were washed, fixed with 2.5% para-formaldehyde, stained for bacteria with DAPI and filamentous actin with TRITC-conjugated phalloidin (Sigma; Knutton et al., [@B34]; Liu et al., [@B36], [@B38]). To quantify pedestal formation, bacteria-associated with actin pedestals was determined as a function of 100 HEp-2 cells examined. One hundred eighty mammalian cells on three coverslips per bacterial preparation were examined in three independent experiments. Significance was determined as previously described (Vingadassalom et al., [@B64]).

Preparation of cell lysates and immunoblotting
----------------------------------------------

For Intimin and Tir expression, 10^8^ bacteria were re-suspended in 20 μL of 1× Laemmli buffer, lysed by heating to 100°C for 10 min and subjected to 10% SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes. Membranes were blocked in PBS + 5% milk (PBSM) before treatment with sheep anti-Intimin (antiserum from a sheep immunized with a C-terminal 300-residues fragment of EHEC 86--24 intimin, gift of A. O'Brien) diluted 1:5000 or rabbit anti-Tir (diluted 1:10,000) antibodies. Following washes, membranes were treated with anti-sheep or anti-rabbit secondary IgG antiserum conjugated to alkaline phosphatase (diluted 1:5000) and developed (Acheson et al., [@B1]).

For Tir translocation, HEp-2 or HeLa cells were seeded into six well tissue culture plates (Becton--Dickinson Labware) and infected with bacterial strains at an MOI of approximately 10 for 6 h. Following infection, the monolayer were washed with PBS to remove unbound bacteria, lifted with Trypsin, centrifuged for 2 min and the pellet was re-suspended in 1× Laemmli buffer and boiled for 10 min. The samples were analyzed by 10% SDS-PAGE and western blotted for Tubulin and Tir (as described above).

Quantification of surface expression of intimin
-----------------------------------------------

An enzyme-linked immunosorbent assay (ELISA) was used to quantify the levels of intimin expression on the bacterial surface (Liu et al., [@B38]). In brief, equivalent numbers of indicated strains (100 μL aliquots of 1 × 10^8^ bacteria/mL) were seeded on poly-[l]{.smallcaps}-lysine-treated 96-well cell culture dishes (Becton--Dickinson Labware), centrifuged for 10 min at 1225 × *g* and incubated at room temperature for 20 min. The bacteria were then fixed with 3% para-formaldehyde for 1 h at room temperature, washed in PBS and blocked with 5% milk in PBS (PBSM) at room temperature for 1 h. Fixed bacteria were probed with Intimin anti-sera for 1 h at room temperature (diluted 1:500). The plates were washed with PBS and PBS + 0.5% Tween-20, followed by addition of the secondary horseradish peroxidase (HRP)-conjugated anti-sheep IgG antibody (diluted 1:10,000 in PBSM; Sigma). Parallel plates were subjected to anti-O157 antiserum (Difco) diluted 1:1000 in PBSM followed by probing with HRP-conjugated anti-rabbit IgG (Sigma) diluted in PBSM to determine the relative number of bound bacteria. The LPS signal obtained for the different bacterial strains within each experiment were within 5%. The mean OD~600~ values (±SD) of quadruplicate samples after subtraction of background (i.e., signal when the primary antibody was omitted) and normalized to bacterial number are shown.

Bacterial binding and pedestal formation in prime and challenge assays
----------------------------------------------------------------------

To assess functional Tir delivery, a "prime and challenge" assay was used (Vingadassalom et al., [@B64]). HEp-2 monolayers were infected with 5 × 10^5^ of either host-adapted or *in vitro*-cultivated EHECΔ*eae* or EHECΔ*tir* with or without plasmid pKC16 (aka pTir) for 3 h, gentamicin (100 μg/ml) treated for 30 min to kill priming bacteria, and challenged with 5 × 10^5^ either native *E. coli* K-12 (vector or un-transformed controls) or *E. coli* K-12 expressing intimin from plasmid pHL6 (aka pInt) and incubated for an additional 3 h at 37°C. To assess bacterial binding, monolayers were lysed and serially plated as described above. To assess actin pedestal formation, infected monolayers were examined microscopically as described above. Significance was determined as previously described (Vingadassalom et al., [@B64]).

Results
=======

Host-adapted EHEC bind and generate actin pedestals on cultured mammalian cells more efficiently than *in vitro*-cultivated EHEC
--------------------------------------------------------------------------------------------------------------------------------

To test whether EHEC adapts to the mammalian host environment by altering its ability to interact with mammalian cells, we cultivated EHEC O157:H7 strain EDL933 under conditions that have been previously developed to maximize host cell interaction and pedestal formation ("*in vitro*-cultured"; Ebel et al., [@B20]), or isolated them from the large bowel of gnotobiotic piglets 24--48 h following oral infection ("host-adapted"; see [Materials and Methods](#s1){ref-type="sec"}). Mammalian cell monolayers were infected with either of these two preparations of EHEC and actin pedestal formation was quantified. Whereas less than 5 actin pedestals were observed per 100 mammalian cells for *in vitro*-cultured EHEC, almost 50 pedestals were observed for the same strain after host adaptation (Figure [1](#F1){ref-type="fig"}A). Similar results were observed under identical conditions using HeLa instead of HEp-2 cells (data not shown). This change does not appear to be hereditable because growth of host-adapted bacteria overnight *in vitro* resulted in a complete reversal of enhanced cell attachment activity (data not shown).

![**Enterohemorrhagic *Escherichia coli* actin pedestal formation and adhesion are enhanced upon host adaptation**. **(A)** Mammalian cell monolayers were infected with host-adapted EHEC (top), *in vitro*-cultured EHEC (middle) or *in vitro*-cultured EHEC ectopically expressing the afimbrial adhesin AFA-1 (bottom). Bacteria were stained with DAPI ("EHEC") and actin pedestals with Alexa568-phalloidin ("F-actin"). The percentage of actin pedestals (±SD) per 100 mammalian cells was determined visually (right). **(B)** Binding of the same three strains to mammalian cell monolayers was determined by plating for viable counts. Data represent the mean ± SD from three independent experiments. \**P* ≤ 0.05.](fmicb-02-00226-g001){#F1}

Host-adapted EHEC also appeared to bind to mammalian cells much more efficiently than did *in vitro*-cultivated EHEC (Figure [1](#F1){ref-type="fig"}A, "EHEC," compare top two rows). When we quantified viable bacterial counts after lysis of infected monolayers, we found that whereas only 0.2% of *in vitro*-cultivated EHEC bound to monolayers, more than 5% of host-adapted bacteria bound to cells, representing a more than 25-fold increase (Figure [1](#F1){ref-type="fig"}B). Thus, adaptation to the mammalian host results in dramatic increases in both cell attachment and pedestal formation by EHEC.

To determine whether the high efficiency of actin pedestal formation upon host adaptation was solely a consequence of its enhanced ability to bind to monolayers, we required a means to dramatically increase mammalian cell binding of *in vitro*-cultured EHEC. Accordingly, we ectopically expressed the afimbrial adhesion AFA-1 from uropathogenic *E. coli*, encoded on pIL22 to artificially increased mammalian cell binding (Labigne-Roussel et al., [@B35]). Indeed, AFA-1 increased cell attachment by *in vitro*-cultivated EHEC to a level comparable to that observed for host-adapted EHEC (Figure [1](#F1){ref-type="fig"}B). Nevertheless, this enhanced cell binding was not associated with a significant increase in the frequency of actin pedestals (Figure [1](#F1){ref-type="fig"}A). Thus, the higher efficiency of pedestal formation by host-adapted EHEC is not simply a consequence of increased cell binding, suggesting that host adaptation results in expression of EHEC products that specifically contribute to actin signaling.

Intimin expression is increased during host adaptation but is not solely responsible for enhanced pedestal formation
--------------------------------------------------------------------------------------------------------------------

Given that intimin participates in cell attachment and pedestal formation, we assessed the relative levels of this adhesin expressed by *in vitro*-cultivated and host-adapted EHEC by Western blotting. As expected, no intimin was detected in extracts of *in vitro*-cultivated EHECΔ*eae* (Figure [2](#F2){ref-type="fig"}A, rightmost lane). Greater amounts of intimin were produced by host-adapted than by *in vitro*-cultivated EHEC (Figure [2](#F2){ref-type="fig"}A, first two lanes). Densitometric analysis suggested a fourfold increase, but was complicated by the multitude of intimin-related species that are typically produced (data not shown; Donnenberg et al., [@B18]; McKee and O'Brien, [@B41]; Agin and Wolf, [@B2]; Liu et al., [@B38]). The apparent increase in expression of intimin in whole cell lysates by host-adapted bacteria was reflected in the level of surface protein detected by ELISA of intact bacteria using anti-intimin antiserum, which revealed that host-adapted bacteria expressed more than threefold higher levels of the adhesin on their surface than their *in vitro*-cultivated counterparts (Figure [2](#F2){ref-type="fig"}B).

![**Intimin expression is increased during host adaptation but is not solely responsible for enhanced pedestal formation**. **(A)** Equivalent numbers of bacteria were utilized to generate bacterial lysates of host-adapted or *in vitro*-cultivated EHEC that were subjected to immunoblotting using anti-intimin antibody. The *in vitro*-cultivated EHEC included wild type bacteria ±pInt, a plasmid that encodes intimin (pInt, lane 3), and EHECΔ*eae*, which does not express intimin (lane 4). Molecular weight markers are indicated at left. **(B)** Equivalent numbers of the indicated strains were added to microtiter wells, fixed, and the relative number of bound bacteria was normalized by ELISA using anti-O157 antiserum. Parallel microtiter wells were subjected to anti-intimin ELISA to determine relative intimin surface expression. Shown are the mean OD~600~ values (±SD) of quadruplicate samples after subtraction of background (i.e., signal when the primary antibody was omitted) and normalized to bacterial number. **(C)** The percent of bacteria bound, determined by plating for viable counts, and the frequency of pedestal formation was determined as described in Figure [1](#F1){ref-type="fig"}. ND, not detected. \**P* ≤ 0.05.](fmicb-02-00226-g002){#F2}

In addition to promoting pedestal formation by binding to Tir, intimin may enhance binding by recognizing mammalian proteins, such as β1-chain integrins (Frankel et al., [@B22]) and nucleolin (Sinclair and O'Brien, [@B57]). To determine whether intimin overexpression by host-adapted EHEC can account for the observed high efficiency of actin pedestal formation, we artificially increased intimin expression of *in vitro*-cultured EHEC by introducing a plasmid ("pInt") that encodes intimin. When evaluated by immunoblotting for total intimin and ELISA for surface expression, EHEC harboring pInt expressed levels of intimin comparable to those achieved upon host adaptation (Figures [2](#F2){ref-type="fig"}A,B, middle lanes), while EHEC harboring a control vector expressed levels of intimin comparable to *in vitro*-cultured WT (data not shown). However, the overexpression of intimin by *in vitro*-cultivated EHEC did not result in a concomitant increase in either host cell binding or actin pedestal formation (Figure [2](#F2){ref-type="fig"}C).

To determine whether the increased production of intimin by host-adapted bacteria is responsible the enhanced mammalian binding we observed, we tested cell binding of an EHEC *eae* mutant, which cannot produce intimin. We found that although host-adapted EHEC *eae* was, as predicted, completely incapable of generating actin pedestals (Figure [2](#F2){ref-type="fig"}C, right), this strain bound to mammalian cells indistinguishably from host-adapted wild type EHEC. Thus, the high level of mammalian cell binding observed for host-adapted EHEC does not reflect intimin-mediated attachment. Clearly, other bacterial factors are required to account for the high efficiency of cell interaction observed upon host adaptation of EHEC.

Tir expression is increased during host adaptation but is not solely responsible for enhanced pedestal formation
----------------------------------------------------------------------------------------------------------------

Translocated intimin receptor and intimin are expressed from a co-transcribed mRNA (Sanchez-SanMartin et al., [@B55]) so we also compared Tir expression by host-adapted or *in vitro*-cultivated bacteria. Immunoblot analysis of cell lysates revealed that an \~80 kDa species that Tir production by host-adapted bacteria was considerably greater than by *in vitro*-cultured EHEC (Figure [3](#F3){ref-type="fig"}A, lanes 1 and 2); densitometric analyses suggested an approximately fivefold increase (data not shown).

![**Translocated intimin receptor expression is increased during host adaptation but is not solely responsible for enhanced pedestal formation**. **(A)** Equivalent numbers of bacteria were utilized to generate bacterial lysates of host-adapted or *in vitro*-cultivated EHEC that were subjected to immunoblotting using anti-intimin antibody. The *in vitro*-cultivated EHEC included wild type bacteria ± pTir a plasmid that encodes Tir (pTir, lane 3), and EHECΔ*tir* (lane 4). Molecular weight is indicated at left. **(B)** Percent bacteria bound and the frequency of pedestal formation was determined as described in Figure [1](#F1){ref-type="fig"}. ND, not detected.\**P* ≤ 0.05.](fmicb-02-00226-g003){#F3}

To determine if the increase in Tir expression was responsible for the enhanced adherence and pedestal formation by host-adapted bacteria, we introduced a high-copy plasmid expressing Tir (pTir) into EHEC that resulted in the levels of Tir expression comparable to that of host-adapted EHEC (Figure [3](#F3){ref-type="fig"}A, lane 3). Consistent with the observation that adherence to monolayers was not influenced by the absence or overexpression of intimin (Figure [2](#F2){ref-type="fig"}), the absence or overexpression of Tir also had no effect on binding of *in vitro*-cultivated EHEC to mammalian cells (Figure [3](#F3){ref-type="fig"}B). In addition, overexpression of Tir by *in vitro*-cultivated EHEC did not result in an increase in pedestal formation (Figure [3](#F3){ref-type="fig"}B, right). These data indicate that although Tir production is increased upon host adaptation, this increase is not sufficient to account for the dramatic increase in the ability to generate actin pedestals upon growth in the mammalian host.

Host adaptation results in increased Tir translocation
------------------------------------------------------

### Tir functions to promote cell attachment and pedestal formation only after insertion into the mammalian cell plasma membrane

After translocation into the mammalian host, EHEC Tir becomes serine phosphorylated by PKA, a modification that can be detected by an increase in apparent molecular mass upon SDS-PAGE (DeVinney et al., [@B16]; Warawa and Kenny, [@B66]). To assess the relative Tir translocation efficiencies, we infected HeLa cell monolayers with equivalent numbers of either host-adapted or *in vitro*-cultivated EHEC, and characterized the amount of modified Tir by Western blotting (Kenny, [@B32]). Analysis of replicate samples revealed that host-adapted EHEC translocates a significantly greater amount of Tir into monolayers than *in vitro* grown EHEC (Figure [4](#F4){ref-type="fig"}, compare lanes 1 and 2 with lanes 3 and 4). Similar results were observed under identical conditions using HeLa instead of HEp-2 cells (data not shown). Enhanced Tir translocation by host-adapted EHEC is not a simple consequence of enhanced host cell binding, because an increase in modified Tir was not observed when HeLa cells were infected with *in vitro*-cultivated EHEC that is highly adhesive by virtue of expressing AFA-1 (Figure [4](#F4){ref-type="fig"}, lane 5). Importantly, since there is approximately equivalent amounts of modified Tir, Tir translocation appears to be independent of AFA-1-mediated enhanced cell binding, suggesting that ectopic expression of AFA-1 neither increased nor decreased the efficiency of type III secretion (Figure [4](#F4){ref-type="fig"}, compare lanes 4 and 5).

![**Translocated intimin receptor translocation is enhanced upon host adaptation**. Mammalian cell monolayers were infected for 6 h with equivalent numbers of host-adapted EHEC isolated from the intestine of two different gnotobiotic piglets (lanes 1--2) or *in vitro*-cultured EHEC strains alone (lanes 3--4) or *in vitro*-cultured EHEC harboring a plasmid encoding AFA-1 (lane 5). Lysates of infected monolayers were resolved by SDS-PAGE and immunoblotted for Tir and tubulin. Western blots from a representative experiment are shown. The migration of unmodified and modified Tir is indicated (right), and numbers on the left indicate apparent molecular mass.](fmicb-02-00226-g004){#F4}

### To determine if the apparent increased translocation of Tir by host-adapted bacteria resulted in enhanced Tir function, we utilized a "prime and challenge" assay

We first infected monolayers with either host-adapted or *in vitro*-cultured EHECΔ*eae*, which translocates Tir but is not capable of intimin-mediated binding. Bacteria were removed by gentamicin treatment and washing. These "primed" monolayers were then "challenged" with either an *E. coli* K-12 strain ("K-12") or an *E. coli* strain harboring a plasmid expressing EHEC intimin ("K-12/pInt"), and after washing, bound bacteria were quantified by plating for viable counts.

Binding of *E. coli* K-12/pInt to unprimed mammalian cell monolayers (data not shown), or monolayers primed with *in vitro*-cultured EHECΔ*tir*, was indistinguishable from binding of *E. coli* K-12 (i.e., \~1% of inoculum), indicating that in this experimental system, intimin does not promote binding to an endogenous host cell receptor (Table [2](#T2){ref-type="table"}, top row). *E. coli* K-12/pInt also did not demonstrate significant binding to monolayers primed with *in vitro*-cultured EHECΔ*eae*, indicating that, upon *in vitro* growth, EHEC does not have the ability to translocate sufficient levels of Tir to allow detection in this functional assay (Table [2](#T2){ref-type="table"}, row 2). Artificial overexpression of Tir in this strain, by introduction of pTir, was also not sufficient to promote translocation of functional amounts of Tir (Table [2](#T2){ref-type="table"}, row 3). In contrast, *E. coli* K-12/pInt bound at levels 10-fold above background to monolayers that had been primed with host-adapted EHECΔ*eae* (Table [2](#T2){ref-type="table"}, bottom row). Microscopic visualization of the monolayers after staining bound bacteria and F-actin revealed that *E. coli* K-12/pInt also generated pedestals on these cells, but not on cells primed with *in vitro*-cultured EHECΔ*eae*. These data indicate that growth in the mammalian host results in enhanced levels of translocation.

###### 

**Translocation of functional Tir is enhanced upon host adaptation**.

  Priming strain                   Challenge strain                                   
  -------------------------------- ------------------ ----------- ---- -------------- --------------
  Host-adapted EHECΔ*eae*          None               0.8 ± 0.1   ND   14.0 ± 3.2\*   12.6 ± 1.5\*
  *In vitro*-cultured EHECΔ*eae*   None               0.9 ± 0.3   ND   1.5 ± 0.7      0.0 ± 0.0
  *In vitro*-cultured EHECΔ*tir*   None               0.7 ± 0.5   ND   1.0 ± 0.5      0.0 ± 0.0
  *In vitro*-cultured EHECΔ*eae*   pTir               ND          ND   1.3 ± 0.7      0.0 ± 0.0

*Monolayers were preinfected (or "primed") with host-adapted EHEC, *in vitro*-cultured EHEC, or *in vitro*-cultured EHEC over expressing Tir. Pre-infecting bacteria were removed and primed monolayers were infected ("challenged") with *E. coli* K-12/pInt. Bacterial attachment and actin pedestal formation were determined as described above, and shown are the mean ± SD from three independent experiments. ND, not determined.\**P* ≤ 0.05*.

Discussion
==========

Bacteria are capable of remarkable phenotypic adaptation during mammalian infection and several bacterial pathogens, including the AE pathogen *C. rodentium*, exhibit enhanced infectivity upon passage through mammalian hosts (Merrell et al., [@B43]; Wiles et al., [@B67]). We hypothesized that host adaptation by EHEC might explain the longstanding paradox that *in vitro*-cultured EHEC typically attach to and generate actin pedestals on mammalian cell monolayers with low efficiency (Karch et al., [@B30]; Cantey and Moseley, [@B12]) yet generate extensive AE lesions on intestinal epithelial cells during mammalian infection (Tzipori et al., [@B62]). In fact, we found that EHEC isolated from the piglet intestine bound to HEp-2 cell monolayers \~25-fold more efficiently and generated actin pedestals with \~10-fold more efficiently than *in vitro*-cultivated bacteria. AE lesion formation is associated with enhanced colonization (Vlisidou et al., [@B65]; Ritchie et al., [@B53]; Crepin et al., [@B15]), and it is tempting to speculate that the increased efficiency of interaction with cultured mammalian cells observed upon host adaptation is associated with the increased colonization efficiency. Indeed, the hyperinfectious phenotype attained by *C. rodentium* following passage through mice is associated with greater host cell binding and pedestal formation, similar to that observed in this study (Wiles et al., [@B67]; Bishop et al., [@B6]).

Host-adapted bacteria produced significantly higher levels of intimin and Tir, two proteins documented to promote both bacterial adhesion and localized actin assembly (Jerse et al., [@B29]; Kenny et al., [@B33]). However, the enhanced cell attachment phenotype by host-adapted EHEC did not require intimin expression, and this intimin-independence suggests that Tir is also unlikely to be required for this phenotype. In addition, artificially increasing levels of these proteins by *in vitro*-cultivated bacteria was not sufficient to phenocopy host-adapted EHEC. Several EHEC surface proteins have been demonstrated or postulated to promote attachment to mammalian cells (i.e., AidA, Iha, Lpf, ToxB, HCP; Ebel et al., [@B21]; Spears et al., [@B58]; Xicohtencatl-Cortes et al., [@B69]; Yin et al., [@B70],[@B71], [@B72]), but the role of any of these adhesins in binding of host-adapted EHEC remains to be demonstrated.

The high efficiency of cell attachment and pedestal formation by host-adapted EHEC appeared to be at least in part a manifestation of enhanced type III translocation. Immunoblotting of extracts of infected monolayers suggested that the translocated effector Tir was delivered more efficiently to mammalian cells by host-adapted than by *in vitro*-cultivated EHEC. In addition, in an assessment of Tir translocation that depends on the detection of two critical Tir functions, we found that preinfection of monolayers with host-adapted but not *in vitro*-cultured bacteria resulted in significantly greater Tir-mediated bacterial binding and actin pedestal formation. Given that actin pedestal formation is largely dependent on a second translocated effector, EspF~U~ (TccP; Campellone et al., [@B10]; Garmendia et al., [@B25]) it appears likely that translocation of at least some other type III effectors is also increased during host adaptation.

The AE pathogens EPEC and *C. rodentium* each encode a type IV pilus capable of retraction that is required for colonization (Donnenberg et al., [@B17]; Mundy et al., [@B44]), and the ability of the EPEC type IV pilus to retract has recently been linked to increased type III translocation and actin pedestal formation (Zahavi et al., [@B73]). Thus, it is tempting to speculate that the EHEC retractable type IV pilus HCP, which appears to be expressed during human infection (Xicohtencatl-Cortes et al., [@B68]), may play a role in promoting cell attachment and type III translocation by host-adapted EHEC. We showed here that artificial enhancement of bacterial binding by the ectopic expression of the afimbrial adhesin AFA-1, which is not capable of retraction, did not result in a concomitant increase in Tir translocation or pedestal formation by *in vitro*-cultured EHEC. Although AFA-1 is not normally expressed in EHEC, it does not appear to interfere with (or enhance) Tir translocation and importantly, and its ectopic expression allowed us to test whether increased pedestal formation was solely a function of increased (albeit artificial) adherence. We cannot exclude the possibility that host-adapted bacteria express one or more adhesin(s) that, by co-ordinated regulation or function with the type III system, facilitate(s) both cell binding and subsequent Tir translocation. Studies to identify the bacterial factor(s) responsible for enhanced cell attachment and pedestal formation by EHEC are ongoing.

Enterohemorrhagic *Escherichia coli dam* and *hfq* mutants, which each suffer pleomorphic regulatory alterations (Murphy et al., [@B46]; Bhatt et al., [@B5]), exhibit increased cell binding, effector translocation, and pedestal formation, similar to that observed here for host-adapted EHEC (Campellone et al., [@B11]; Hansen and Kaper, [@B26]; Shakhnovich et al., [@B56]). It is possible that loss of *dam* or *hfq* function mimics some aspects of host adaptation. The induction of cell attachment and pedestal forming capacities by host-adapted EHEC were lost upon overnight *in vitro* culture (P. Radhakrishnan, M. J. Brady, data not shown), indicating that these phenotypes are due to a reversible alteration by EHEC growing in the host, similar to the transient nature of enhanced host cell interaction by *C. rodentium* (Bishop et al., [@B6]). Although the regulation of the LEE pathogenicity island that encodes the type III translocation system of AE pathogens has been studied extensively (Ando et al., [@B3]; Musken et al., [@B47]; House et al., [@B28]; for review, see Mellies et al., [@B42]), it is not known what environmental signal(s) results in host adaptation by EHEC. Quorum sensing and growth phase have been shown to regulate virulence factors of AE or other intestinal pathogens (Puente et al., [@B51]; Sperandio et al., [@B59]; Antunes et al., [@B4]). However, manipulation of the growth phase of *in vitro*-cultivated EHEC did not result in efficient host cell attachment or actin pedestal formation (P. Radhakrishnan, unpublished observations) and broth cultures of EHEC that achieved approximately the same density of bacteria as was attained in the piglet intestine (\~10^9^ bacteria/ml) bound to and generated pedestals on mammalian cell monolayers inefficiently, indicating that quorum sensing *per se* is not a sufficient trigger for host adaptation in binding and type III translocation. In addition, mammalian factors such as catecholamines have been implicated in the regulation of EHEC virulence, but *in vitro* culture of EHEC in the presence of epinephrine or porcine intestinal mucus did not increase mammalian cell binding or pedestal formation (M. J. Brady and P. Radhakrishnan, unpublished observation). Thus, future studies are required to understand the regulatory pathway(s) responsible for host adaptation by EHEC. Such investigations, as well as studies to identify the microbial products that promote enhanced cell interaction of bacteria growing within the mammalian host, would provide both insight into the pathogenesis of EHEC infection and potential targets for therapeutic intervention.
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